Cooper Companies | COO - Cost Of Sales

Stock Price
61.44
Daily Change
0.50 0.82%
Monthly
-11.55%
Yearly
-24.61%
Q2 Forecast
58.41

Cooper Companies reported $376.8M in Cost of Sales for its fiscal quarter ending in December of 2025.





Cost Of Sales Change Date
Abbott USD 5.3B 380M Mar/2026
Align Technology USD 303.5M 60.47M Mar/2026
AtriCure USD 31.94M 3.22M Mar/2026
Avanos Medical USD 88M 6.9M Mar/2026
Bausch Health Companies USD 979M 55M Mar/2026
Baxter International USD 1.81B 587M Mar/2026
Bayer EUR 5.23B 731M Mar/2026
Becton, Dickinson and Co. USD 2.56B 281M Mar/2026
Boston Scientific USD 1.83B 8M Mar/2026
Cooper Companies USD 376.8M 87.4M Dec/2025
Dentsply International USD 453M 65M Mar/2026
Dexcom USD 441.6M 25.3M Mar/2026
Edwards Lifesciences USD 362.6M 19.6M Mar/2026
Globus Medical USD 263.59M 26.88M Mar/2026
Haemonetics USD 136.58M 4.01M Dec/2025
Inogen USD 39.59M 1.27M Sep/2024
Insulet USD 232.7M 17.5M Mar/2026
Integra LifeSciences USD 178.71M 14.73M Mar/2026
Intuitive Surgical USD 940.3M 21.6M Mar/2026
J&J USD 8.07B 103M Mar/2026
Medtronic USD 3.61B 83M Dec/2025
Merit Medical Systems USD 197.08M 1.5M Mar/2026
Novartis USD 3.54B 7M Dec/2025
ResMed USD 551.67M 4.17M Mar/2026
STAAR Surgical USD 24.66M 10.6M Mar/2026
Steris USD 891.3M 50.6M Mar/2026
Stryker USD 2.36B 325M Mar/2026
Tandem Diabetes Care USD 122.92M 7.96M Dec/2025
Teleflex USD 240.84M 20.7M Mar/2026
Utah Medical Products USD 3.78M 419K Dec/2025
Zimmer Biomet Holdings USD 738.3M 231.8M Mar/2026